Correlation Between Procaps Group and Universe Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Procaps Group and Universe Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procaps Group and Universe Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Procaps Group SA and Universe Pharmaceuticals, you can compare the effects of market volatilities on Procaps Group and Universe Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procaps Group with a short position of Universe Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procaps Group and Universe Pharmaceuticals.

Diversification Opportunities for Procaps Group and Universe Pharmaceuticals

0.87
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Procaps and Universe is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Procaps Group SA and Universe Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universe Pharmaceuticals and Procaps Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procaps Group SA are associated (or correlated) with Universe Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universe Pharmaceuticals has no effect on the direction of Procaps Group i.e., Procaps Group and Universe Pharmaceuticals go up and down completely randomly.

Pair Corralation between Procaps Group and Universe Pharmaceuticals

Given the investment horizon of 90 days Procaps Group SA is expected to generate 1.48 times more return on investment than Universe Pharmaceuticals. However, Procaps Group is 1.48 times more volatile than Universe Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Universe Pharmaceuticals is currently generating about -0.26 per unit of risk. If you would invest  264.00  in Procaps Group SA on December 21, 2024 and sell it today you would lose (117.00) from holding Procaps Group SA or give up 44.32% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Procaps Group SA  vs.  Universe Pharmaceuticals

 Performance 
       Timeline  
Procaps Group SA 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Procaps Group SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Procaps Group is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Universe Pharmaceuticals 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Procaps Group and Universe Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Procaps Group and Universe Pharmaceuticals

The main advantage of trading using opposite Procaps Group and Universe Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procaps Group position performs unexpectedly, Universe Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universe Pharmaceuticals will offset losses from the drop in Universe Pharmaceuticals' long position.
The idea behind Procaps Group SA and Universe Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bonds Directory
Find actively traded corporate debentures issued by US companies